Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) EPS (Weighted Average and Diluted): 2023-2025

Historic EPS (Weighted Average and Diluted) for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$0.63.

  • Upstream Bio's EPS (Weighted Average and Diluted) rose 90.95% to -$0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.69, marking a year-over-year increase of 146.10%. This contributed to the annual value of -$5.58 for FY2024, which is 56.91% up from last year.
  • Upstream Bio's EPS (Weighted Average and Diluted) amounted to -$0.63 in Q3 2025, which was up 14.86% from -$0.74 recorded in Q2 2025.
  • Upstream Bio's 5-year EPS (Weighted Average and Diluted) high stood at $12.57 for Q4 2024, and its period low was -$6.96 during Q3 2024.
  • For the 3-year period, Upstream Bio's EPS (Weighted Average and Diluted) averaged around -$1.62, with its median value being -$2.11 (2023).
  • The largest annual percentage gain for Upstream Bio's EPS (Weighted Average and Diluted) in the last 5 years was 348.91% (2024), contrasted with its biggest fall of 229.86% (2024).
  • Over the past 3 years, Upstream Bio's EPS (Weighted Average and Diluted) (Quarterly) stood at -$5.05 in 2023, then spiked by 348.91% to $12.57 in 2024, then skyrocketed by 90.95% to -$0.63 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.63 in Q3 2025, compared to -$0.74 in Q2 2025 and -$0.51 in Q1 2025.